Copyright
©The Author(s) 2017.
World J Hematol. Feb 6, 2017; 6(1): 1-10
Published online Feb 6, 2017. doi: 10.5315/wjh.v6.i1.1
Published online Feb 6, 2017. doi: 10.5315/wjh.v6.i1.1
Patient | PNL engraftment (d) | PLT engraftment (d) | Acute GVHD | Chronic GVHD | Post-transplant disease status | Last status |
1 | 12 | 18 | No | No | Molecular relapse and granulocytic sarcoma | Died |
2 | 15 | 16 | No | No | Blastic crises | Died |
3 | 18 | 30 | No | No | Remission | Died |
4 | 14 | 14 | Yes | No | Remission | Died |
5 | 25 | 21 | Yes | Yes | Remission | Alive |
6 | 19 | 15 | Yes | No | Remission | Died |
7 | 10 | 10 | No | No | Remission | Alive |
8 | 10 | 10 | Yes | No | Remission | Died |
9 | 11 | 14 | Yes | No | Remission | Alive |
10 | 12 | 13 | Yes | No | Remission | Died |
- Citation: Soyer N, Uysal A, Tombuloglu M, Sahin F, Saydam G, Vural F. Allogeneic stem cell transplantation in chronic myeloid leukemia patients: Single center experience. World J Hematol 2017; 6(1): 1-10
- URL: https://www.wjgnet.com/2218-6204/full/v6/i1/1.htm
- DOI: https://dx.doi.org/10.5315/wjh.v6.i1.1